Wegovy, the weight-loss medication, gets FDA approval for use as heart disease prevention drug
Wegovy has been FDA-approved for heart disease prevention. The semaglutide, originally approved for weight loss, is now approved to reduce the risk of cardiovascular death, heart attack and stroke.
Ozempic, Wegovy and other weight loss drugs present holiday challenges
Holiday prep may include forgoing doses for some people taking medications popularly used to facilitate weight loss. Those who do that need to be careful when resuming them, an expert said.
Novo Nordisk shares fall after media report on quality lapses at US plant
Novo Nordisk, a pharmaceutical company, experienced a decline in its stock prices following a report by financial news agency MarketWire.